OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Severe COVID-19 is a T cell immune dysregulatory disorder triggered by SARS-CoV-2
Rohan Ameratunga, See‐Tarn Woon, Richard Steele, et al.
Expert Review of Clinical Immunology (2022) Vol. 18, Iss. 6, pp. 557-565
Closed Access | Times Cited: 13
Rohan Ameratunga, See‐Tarn Woon, Richard Steele, et al.
Expert Review of Clinical Immunology (2022) Vol. 18, Iss. 6, pp. 557-565
Closed Access | Times Cited: 13
Showing 13 citing articles:
Is SARS-CoV-2 the only cause of long-COVID?
Ilduara Pintos, Víctor Moreno‐Torres, Fátima Ibáñez-Estéllez, et al.
Aids Reviews (2022) Vol. 24, Iss. 4
Open Access | Times Cited: 21
Ilduara Pintos, Víctor Moreno‐Torres, Fátima Ibáñez-Estéllez, et al.
Aids Reviews (2022) Vol. 24, Iss. 4
Open Access | Times Cited: 21
Allogeneic, off-the-shelf, SARS-CoV-2-specific T cells (ALVR109) for the treatment of COVID-19 in high-risk patients
Spyridoula Vasileiou, LaQuisa C. Hill, Manik Kuvalekar, et al.
Haematologica (2022) Vol. 108, Iss. 7, pp. 1840-1850
Open Access | Times Cited: 20
Spyridoula Vasileiou, LaQuisa C. Hill, Manik Kuvalekar, et al.
Haematologica (2022) Vol. 108, Iss. 7, pp. 1840-1850
Open Access | Times Cited: 20
SARS-CoV-2 evolution has increased resistance to monoclonal antibodies and first-generation COVID-19 vaccines: Is there a future therapeutic role for soluble ACE2 receptors for COVID-19?
Rohan Ameratunga, A. M. Jordan, Klaus Lehnert, et al.
Antiviral Research (2024) Vol. 227, pp. 105894-105894
Closed Access | Times Cited: 2
Rohan Ameratunga, A. M. Jordan, Klaus Lehnert, et al.
Antiviral Research (2024) Vol. 227, pp. 105894-105894
Closed Access | Times Cited: 2
SARS-CoV-2 Omicron: Light at the End of the Long Pandemic Tunnel or Another False Dawn for Immunodeficient Patients?
Rohan Ameratunga, Euphemia Leung, See‐Tarn Woon, et al.
The Journal of Allergy and Clinical Immunology In Practice (2022) Vol. 10, Iss. 9, pp. 2267-2273
Open Access | Times Cited: 13
Rohan Ameratunga, Euphemia Leung, See‐Tarn Woon, et al.
The Journal of Allergy and Clinical Immunology In Practice (2022) Vol. 10, Iss. 9, pp. 2267-2273
Open Access | Times Cited: 13
Induction of pulmonary HLA-G expression by SARS-CoV-2 infection
Barbara Seliger, Simon Jasinski‐Bergner, Chiara Massa, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 11
Open Access | Times Cited: 13
Barbara Seliger, Simon Jasinski‐Bergner, Chiara Massa, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 11
Open Access | Times Cited: 13
SARS-CoV-2 the ASIA virus (Autoimmune/autoinflammatory Syndrome Induced by Adjuvants), the risk of infertility and vaccine hesitancy
Rohan Ameratunga
Expert Review of Vaccines (2022) Vol. 21, Iss. 9, pp. 1177-1184
Closed Access | Times Cited: 10
Rohan Ameratunga
Expert Review of Vaccines (2022) Vol. 21, Iss. 9, pp. 1177-1184
Closed Access | Times Cited: 10
The autoimmune rheumatological presentation of Common Variable Immunodeficiency Disorders with an overview of genetic testing
Rohan Ameratunga, See‐Tarn Woon, Euphemia Leung, et al.
Seminars in Arthritis and Rheumatism (2024) Vol. 65, pp. 152387-152387
Closed Access | Times Cited: 1
Rohan Ameratunga, See‐Tarn Woon, Euphemia Leung, et al.
Seminars in Arthritis and Rheumatism (2024) Vol. 65, pp. 152387-152387
Closed Access | Times Cited: 1
Selective IgA Deficiency May Be an Underrecognized Risk Factor for Severe COVID-19
Rohan Ameratunga, Euphemia Leung, See‐Tarn Woon, et al.
The Journal of Allergy and Clinical Immunology In Practice (2022) Vol. 11, Iss. 1, pp. 181-186
Open Access | Times Cited: 8
Rohan Ameratunga, Euphemia Leung, See‐Tarn Woon, et al.
The Journal of Allergy and Clinical Immunology In Practice (2022) Vol. 11, Iss. 1, pp. 181-186
Open Access | Times Cited: 8
Will SARS-CoV-2 impact the incidence and nature of other respiratory infections?
Ahmad Z. Al Meslamani
Expert Review of Clinical Immunology (2023) Vol. 19, Iss. 12, pp. 1431-1434
Open Access | Times Cited: 3
Ahmad Z. Al Meslamani
Expert Review of Clinical Immunology (2023) Vol. 19, Iss. 12, pp. 1431-1434
Open Access | Times Cited: 3
Critical role of diagnostic SARS-CoV-2 T cell assays for immunodeficient patients
Rohan Ameratunga, See‐Tarn Woon, Richard Steele, et al.
Journal of Clinical Pathology (2022) Vol. 75, Iss. 12, pp. 793-797
Closed Access | Times Cited: 4
Rohan Ameratunga, See‐Tarn Woon, Richard Steele, et al.
Journal of Clinical Pathology (2022) Vol. 75, Iss. 12, pp. 793-797
Closed Access | Times Cited: 4
Validation of the T-Lymphocyte Subset Index (TLSI) as a Score to Predict Mortality in Unvaccinated Hospitalized COVID-19 Patients
Andrea Di Lorenzo, Simona Tedde, Pier Giorgio Pace, et al.
Biomedicines (2022) Vol. 10, Iss. 11, pp. 2788-2788
Open Access | Times Cited: 1
Andrea Di Lorenzo, Simona Tedde, Pier Giorgio Pace, et al.
Biomedicines (2022) Vol. 10, Iss. 11, pp. 2788-2788
Open Access | Times Cited: 1
Effect of SARS-CoV2 infection on disease flares in patients with systemic lupus erythematosus: a case–control study
Chi Chiu Mok, Chris Ching Lam Cheung, Kar Li Chan, et al.
Lara D. Veeken (2023)
Closed Access
Chi Chiu Mok, Chris Ching Lam Cheung, Kar Li Chan, et al.
Lara D. Veeken (2023)
Closed Access
Characteristics and outcomes of COVID ‐19 in Chinese immune thrombocytopenia patients: A prospective cohort study
Yunfei Chen, Jiaying Liu, Shuai Shao, et al.
British Journal of Haematology (2023) Vol. 204, Iss. 4, pp. 1207-1218
Closed Access
Yunfei Chen, Jiaying Liu, Shuai Shao, et al.
British Journal of Haematology (2023) Vol. 204, Iss. 4, pp. 1207-1218
Closed Access
